Genmab — Januar 2017
-
GMXAY ligger i 86,06. Vil det sige at den mominelle værdi på en New York Genmab er det halve af CPH?
-
Jeg er enig Budweis.
-
Adam Feuerstein tanker om US biotech i 2017 incl de mest interessante kliniske readouts og de stoffer FDA skal tage stilling til eller som skal lanceres https://www.thestreet.com/story/13939672/1/17-thoughts-on-biotech-stocks-to-kick-off-2017.html
-
God morgen.
-
GENMAB/J.P. MORGAN: ANBEFALING HÆVES TIL OVERVÆGT FRA NEUTRAL
-
GENMAB/JPMORGAN: KURSMÅL HÆVES TIL 1350 KR. FRA 1100 KR.
-
Fokus på Genmab https://play.borsen.dk/klip/586c6a7545628ff8171f7678
-
tak for den fine nyhed hj https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=420533013&sourcecode=ddk
-
Prøv igen transalp.
-
Tak..Jeg burde læse bedre med.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind